Halozyme Therapeutics Inc 2025 Sustainability Report
Company: Halozyme Therapeutics Inc
Sector: Manufacturing
Country: United States
Year: 2025
Type: Sustainability Report
Pages: 50
The report highlights Halozyme's completion of the Elektrofi acquisition in November 2025 and the expansion of its drug-delivery technology portfolio. It reports accounting for Scope 1, Scope 2, and Scope 3 emissions, completion of a California climate risk assessment, and registration to establish a science-based target. Operational highlights include transitioning 51% of the vehicle fleet to hybrids and diverting nearly three tons of laboratory solid waste and plastics from landfills.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.